LightDeck Diagnostics, a company formed earlier this year from the merger of startups mBio and Brava Diagnostics, has raised $11 million in funding for a new high-speed COVID-19 test, according to a statement. The company’s novel test uses planar wave guide technologies to rapidly assess the presence of specific pathogens in a patient. After collecting […]...